Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.

Nature genetics·2026
Same author

Response to: "Clearing the fog, but not the entire picture: Elastase pretreatment for ALK FISH in lung cancer".

Biomedical journal·2026
Same author

Seq2Karyotype (S2K): A Method for <i>in-silico</i> Karyotyping Using Single-Sample Whole-Genome Sequencing Data.

bioRxiv : the preprint server for biology·2025
Same author

Novel Computational Photography for Soft-Focus Effect in Automatic Post Production.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025
Same author

Elastase reduces background autofluorescence in ALK fluorescence in situ hybridization assays for lung cancers.

Biomedical journal·2025
Same author

Evaluation of the immunological functions of placental alkaline phosphatase <i>in vivo</i> using ALPP transgenic mice.

Frontiers in immunology·2025

Related Experiment Video

Updated: Sep 25, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

An integrated network representation of multiple cancer-specific data for graph-based machine learning.

Limeng Pu1, Manali Singha2, Hsiao-Chun Wu3

  • 1Center for Computation and Technology, Louisiana State University, Baton Rouge, LA, 70803, USA.

NPJ Systems Biology and Applications
|April 29, 2022
PubMed
Summary
This summary is machine-generated.

Integrating diverse cancer data into unified graphs improves drug response prediction. This novel graph-based approach enhances machine learning accuracy compared to traditional methods, advancing cancer pharmacotherapy insights.

More Related Videos

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

883

Related Experiment Videos

Last Updated: Sep 25, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

883

Area of Science:

  • Computational biology
  • Bioinformatics
  • Cancer genomics

Background:

  • Genomic profiles offer insights into cancer genetic alterations.
  • Predicting cancer cell line drug response using genomics alone is challenging due to cancer's complexity.
  • Existing methods often struggle with multifactorial phenotypes and intricate cancer mechanisms.

Purpose of the Study:

  • To develop a novel method for integrating heterogeneous cancer data into a unified graph structure.
  • To improve the prediction accuracy of cancer cell line drug response.
  • To leverage system-level complexity for more effective pharmacotherapy prediction.

Main Methods:

  • Integration of biological networks, genomics, inhibitor profiling, and gene-disease associations into a unified graph.
  • Development of a novel graph reduction algorithm to create compact, information-rich cancer-specific networks.
  • Utilizing a tissue-level cross-validation protocol for benchmarking.

Main Results:

  • A graph-based predictor achieved an accuracy of 0.68 in predicting drug efficacy.
  • The developed method significantly outperformed traditional matrix-based techniques.
  • Non-Euclidean representation of cancer data enhanced machine learning performance.

Conclusions:

  • Integrating diverse biological data into graph structures is a powerful approach for cancer research.
  • The novel graph reduction algorithm effectively preserves crucial biological and topological information.
  • This methodology offers a promising advancement in predicting cancer pharmacotherapy response.